(Q46606421)

23 December 2017

title

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial (English)

1 reference

23 December 2017

progressive supranuclear palsy

0 references

1 reference

1 reference

based on heuristic

inferred from title

author

Carmen Schade-Brittinger

9

object named as

Carmen Schade-Brittinger

1 reference

23 December 2017

10

Wolfgang H Oertel

1 reference

23 December 2017

1

Maria Stamelou

1 reference

23 December 2017

6

Karla M Eggert

1 reference

23 December 2017

author name string

Alexander Reuss

2

1 reference

23 December 2017

Ulrich Pilatus

3

1 reference

23 December 2017

Jörg Magerkurth

4

1 reference

23 December 2017

Petra Niklowitz

5

1 reference

23 December 2017

Andrea Krisp

7

1 reference

23 December 2017

Thomas Menke

8

1 reference

23 December 2017

Günter U Höglinger

11

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

23 December 2017

published in

Movement Disorders

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

942-949

1 reference

23 December 2017

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

cites work

1 reference

Progressive supranuclear palsy: where are we now?

21 January 2018

1 reference

A clinical rating scale for progressive supranuclear palsy

21 January 2018

1 reference

Current and future treatments in progressive supranuclear palsy

21 January 2018

1 reference

Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group

21 January 2018

1 reference

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

21 January 2018

1 reference

Mitochondrial dysfunction in progressive supranuclear palsy

21 January 2018

1 reference

Therapeutic role of coenzyme Q(10) in Parkinson's disease

21 January 2018

1 reference

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

21 January 2018

1 reference

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

21 January 2018

1 reference

Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease

21 January 2018

1 reference

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi.

21 January 2018

1 reference

FDG PET in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22023

1 reference

23 December 2017

1 reference

23 December 2017